When to choose an endocrinologist: If you have type 2 diabetes with complex management needs, complications from diabetes, other hormonal conditions, or if your primary care doctor recommends specialist management
GLP-1 RAs may attenuate inflammatory response by down-regulating NF-kB signalling
Wegovy and Ozempic, which both contain semaglutide, begin at much lower dosages of 0.25 mg weekly
2023 Apr;24(2):69 Zahabi G, Ilic V, Garca-Ramos A, Cokorilo N
IGF-I is a mediator of growth hormone action
Recently, Pfizer also successfully secured the ownership of GLP-1 biotechnology company Metsera after a surprise bidding conflict, adding Metseras injectable asset, MET-097i (which is in Phase 2b testing and has the potential for once-a-month dosing), to its portfolio